Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Trials
Collaboration
Funding
Research Alliance
Lunit, Japan national cancer center collaborate on AI-based pathology for oncology
In collaborative studies with the national cancer center, researchers are evaluating the potential of the Lunit Scope artificial intelligence biomarker platform to predict clinical outcomes for rectal cancer.
May 30, 2023
Illumina, Myriad Genetics provide U.S. access to HRD research test
The expanded partnership establishes a companion diagnostic (CDx) testing alliance for the pharmaceutical industry, which will enable more clinical research for gene-based, targeted therapies, the firms said.
March 6, 2023
Roche, Janssen expand collaboration to develop CDx tests for targeted therapies
The collaboration involves numerous companion diagnostics technologies, including immunohistochemistry, digital pathology, next generation sequencing, PCR, and immunoassays.
February 9, 2023
Mayo Clinic, Numares Health expand collaboration, develop AI-enabled diagnostic testing for chronic disease
Expanding upon Mayo Clinic’s clinical research support for Numares Health, the collaboration will focus on researching and developing AI-enabled diagnostic testing solutions.
November 3, 2022
PacBio partners with Broad Institute, 10x Genomics to launch single-cell RNA sequencing kit
The kit will help single-cell researchers better identify and characterize novel isoforms, novel driver mutations, and cancer fusion genes for research into cancers and neurodegenerative diseases.
October 20, 2022
Broad Institute, Dana-Farber, St. Jude Children's Research Hospital collaborate on pediatric cancers
The organizations said they will invest more than $60 million over five years to support a collaboration called the Pediatric Cancer Dependencies Accelerator project.
October 13, 2022
PathAI partners with Roche for AI tech
The companies said the partnership allows for broad access to digital pathology diagnostics to support clinical research and companion diagnostic programs globally.
October 14, 2021
MD Anderson, BostonGene enter into strategic alliance
The agreement expands upon existing research collaborations between BostonGene and multiple center researchers. MD Anderson and BostonGene will work together on clinical utility studies designed to support incorporating BostonGene testing into national guidelines and adoption as a national standard of care.
September 30, 2021
Pershing Square Foundation funds SARS-CoV-2 research
The researchers typically focus on cancer research but are instead using their expertise to better understand SARS-CoV-2, the virus that causes COVID-19. The winning projects include a variety of research topics related to COVID-19 and SARS-CoV-2, including potential treatments, genetic or immune determinants, and testing.
July 7, 2020
Is whole genome sequencing for children with rare diseases worth the price?
WGS has been proposed as a possible shortcut out of the "diagnostic odyssey," the ordeal endured by patients with rare diseases as they undergo a seemingly endless series of clinical evaluations, imaging studies, and laboratory tests before obtaining a diagnosis.
June 29, 2020
San Diego research institutes study spread of COVID-19
The new collaboration is called the San Diego Epidemiology and Research for COVID Health (SEARCH) alliance. The cross-institutional group is co-led by clinical researchers at Rady Children's Hospital-San Diego, Rady Children's Institute for Genomic Medicine, Scripps Research, and the University of California (UC), San Diego.
June 15, 2020
Taking time out for genetic testing in acute myeloid leukemia may be OK
The retrospective real-world study evaluated outcomes for AML patients included in the Study Alliance Leukemia (SAL) AML registry, which includes 46 treatment centers in Germany. Researchers set out to evaluate how differences in the length of time from diagnosis to start of treatment correlated with overall survival and other key outcomes in patients newly diagnosed with and previously untreated for AML.
June 4, 2020
Page 1 of 2
Next Page
